Artia Global Partners’s SpringWorks Therapeutics SWTX Stock Holding History

Artia Global Partners’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-63,930	Closed	-$3M	–	53
2025 Q2	$3M	Buy	63,930 +10,000	+19%	+$445K	0.72%	19
2025 Q1	$2.38M	Hold	53,930	–	–	0.6%	21
2024 Q4	$1.95M	Hold	53,930	–	–	0.7%	24
2024 Q3	$1.73M	Hold	53,930	–	–	0.47%	24
2024 Q2	$2.03M	Hold	53,930	–	–	0.39%	27
2024 Q1	$2.65M	Buy	+53,930	New	+$2.49M	0.53%	22

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Artia Global Partners's SWTX Position: Q3 2025 in Review

Artia Global Partners sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 63,930 shares — an estimated $3M sold.

Artia Global Partners first reported a position in SWTX in Q1 2024 and held it in 6 quarters. The position peaked at $3M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Artia Global Partners reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Artia Global Partners sold 63,930 SpringWorks Therapeutics shares in Q3 2025, an estimated $3M.
Artia Global Partners first reported a position in SpringWorks Therapeutics in Q1 2024 and held it in 6 quarters.
Artia Global Partners's SpringWorks Therapeutics position peaked at $3M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Artia Global Partners's 13F filing for Q3 2025, filed 14 Nov 2025.